Nuvation Bio Inc.
NUVB
$2.23
-$0.13-5.51%
NYSE
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -53.24M | -49.45M | -41.21M | -462.49M | -14.79M |
| Total Depreciation and Amortization | 310.00K | 219.00K | 162.00K | 244.00K | 58.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 7.54M | 9.67M | 4.99M | 431.05M | 3.64M |
| Change in Net Operating Assets | 2.76M | -6.75M | 4.97M | -6.13M | -4.61M |
| Cash from Operations | -42.63M | -46.30M | -31.09M | -37.32M | -15.70M |
| Capital Expenditure | -72.00K | 13.00K | -148.00K | 0.00 | -27.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -92.00K | 0.00 | 12.52M | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 54.25M | 51.85M | 29.26M | 21.75M | 7.57M |
| Cash from Investing | 54.18M | 51.77M | 29.12M | 34.27M | 7.54M |
| Total Debt Issued | -- | 5.57M | 0.00 | 7.04M | -- |
| Total Debt Repaid | -534.00K | -7.63M | -3.21M | -6.32M | -- |
| Issuance of Common Stock | 1.08M | 1.16M | 1.67M | 2.04M | 21.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 548.00K | -900.00K | -1.54M | 2.75M | 21.00K |
| Foreign Exchange rate Adjustments | 151.00K | 1.12M | -742.00K | 78.00K | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 12.25M | 5.69M | -4.25M | -225.00K | -8.14M |